Aleks Engel

Partner at Novo Holdings · Joined 2014

View Live Interactive Profile →

Biography

Aleks Engel joined Novo Holdings in 2014 and is a Partner in the Planetary Health Investments team, based in Boston. He was previously part of the firm's Principal Investments team and its Seed Investments team in Copenhagen. Before Novo Holdings he was employed by Baxter International, Pfizer Global Research and Development, Thomson Scientific & Healthcare and McKinsey & Company. He holds a PhD in biochemical engineering and an MSc in chemical engineering practice from MIT.

Education

Previous Experience

Notable Investments

Benchmark Genetics

Career Timeline

2014
Joins Novo Holdings, initially in the Seed Investments and Principal Investments teams in Copenhagen.
2024
Quoted as Partner, Planetary Health Investments in Novo Holdings' announcement of its agreement to acquire Benchmark Genetics.

Sources & References

Novo Holdings - Aleks Engel (people page, checked 6 September 2026) ↗Novo Holdings to acquire Benchmark Genetics (25 November 2024) ↗